Happy days are here again in the telecom capex market, right? After all, companies like Juniper (Nasdaq:JNPR), Ciena (Nasdaq:CIEN), and Finisar (Nasdaq:FNSR) have seen their stocks shoot up over the last three months, and even Alcatel-Lucent (NYSE:ALU) is looking viable again. Certainly if Alcatel looks like it could make it, the market must be improving, right?
Well, yes and no. Spending is still lumpy and idiosyncratic, and there
are gaps between what companies are saying about orders (and what
analysts/investors are projecting for 2013/2014) and what's actually
happening in the here and now. And that's where JDSU's (Nasdaq:JDSU)
earnings come into play – JDSU didn't have a bad quarter and management
sounds optimistic about the recovery, but the actual business still
needs time to come around. Of course, those investors who think they can
just wait until they see the recovery in the financials before they buy
the shares may well find that most of the gains have already gone to
others by then.
Please follow this link for more:
http://www.investopedia.com/stock-analysis/081513/jdsus-results-highlight-volatility-telco-capex-recovery-jdsu-fnsr-cien-dhr.aspx
Showing posts with label EXFO. Show all posts
Showing posts with label EXFO. Show all posts
Thursday, August 15, 2013
Friday, March 30, 2012
Investopedia: EXFO Testing Patience
It's important to remember that there are multiple definitions of success out there. Some companies have very successful products, but that doesn't always translate into impressive financial results or outsized stock market performance. Although EXFO (Nasdaq:EXFO) has been quite successful in terms of market and technology leadership in the communications testing business, management has never really translated that success into impressive financial results.
More of the same in Fiscal Second Quarter
Performance has been tough at EXFO for a while now, as major carriers like Verizon (NYSE:VZ) and AT&T (NYSE:T) delay capital spending on their networks. Although EXFO had established a recent string of squeaking by the quarterly expectations but lowering forward looking numbers, this quarter featured both a miss and yet another takedown of guidance.
Please click here for more:
http://stocks.investopedia.
More of the same in Fiscal Second Quarter
Performance has been tough at EXFO for a while now, as major carriers like Verizon (NYSE:VZ) and AT&T (NYSE:T) delay capital spending on their networks. Although EXFO had established a recent string of squeaking by the quarterly expectations but lowering forward looking numbers, this quarter featured both a miss and yet another takedown of guidance.
Please click here for more:
http://stocks.investopedia.
Wednesday, November 23, 2011
Investopedia: If The Economy Holds, Agilent Is A Buy
Put succinctly, Wall Street is still freaked out about the course of the global economy in 2012. As a result, a long list of companies are trading below what seems like a rational fair value, and Agilent (NYSE:A) is clearly among them. Although a further economic slowdown would be bad news for both the test and measurement and life sciences businesses, today's price seems to already factor in a lot of that risk.
An Unnerving Close to the Fiscal Year
Although Agilent's reported results were not bad, it did give nervous investors an excuse to worry a little more. Revenue did rise more than 9% in the fiscal fourth quarter, but the growth rate came in a bit below the expectations of management and many analysts, even if that shortfall could be tied largely to forex moves. Growth was strongest in the electronic measurement segment (up 10% organically), decent in life sciences (up 6%) and sluggish in chemical analysis (up 1%).
Follow this link for the full piece:
http://stocks.investopedia.
An Unnerving Close to the Fiscal Year
Although Agilent's reported results were not bad, it did give nervous investors an excuse to worry a little more. Revenue did rise more than 9% in the fiscal fourth quarter, but the growth rate came in a bit below the expectations of management and many analysts, even if that shortfall could be tied largely to forex moves. Growth was strongest in the electronic measurement segment (up 10% organically), decent in life sciences (up 6%) and sluggish in chemical analysis (up 1%).
Follow this link for the full piece:
http://stocks.investopedia.
Wednesday, August 17, 2011
Investopedia: Agilent Beaten Down To Bargain
You would think that a company with a global revenue base, diverse industry exposure and solid returns on capital would get the benefit of the doubt. But in the case of Agilent (NYSE:A), you would seem to be wrong. Agilent may not command as much respect for technology leadership as a company like Illumina (Nasdaq:ILMN), but Agilent's diverse and growing business deserves more respect and investors should consider using this market pullback as a chance to buy some shares in this high-quality company.
Third Quarter Results Better than Feared
Even though there was not much sign of it in the published analyst estimates, sentiment had definitely been souring on Agilent going into this earnings cycle. Nevertheless, Agilent reported that sales grew more than 22% in the fiscal third quarter, with 19% organic revenue growth. Growth was led by the electronic measurement segment (up almost 24%), where growth in the communications business was especially strong. Life sciences delivered solid 21% growth (18% organic), and chemical analysis was the "laggard" with 16% reported and 11% organic revenue growth.
To read more, click below:
http://stocks.investopedia.
Monday, February 7, 2011
Investopedia: JDS Uniphase Comes Through Loud And Clear
Tech investors have not been too forgiving to companies through this earnings cycle, but JDS Uniphase (Nasdaq:JDSU) largely took matters into its own hands with a stellar result. While there is still plenty of room to debate JDSU's long-term future, the near-term outlook for optoelectronics seems to be pretty strong.
A Blowout in the Fiscal Second Quarter
JDS Uniphase delivered everything investors wanted in its fiscal second quarter and then some. Revenue jumped 16% from the first quarter (and 39% from the year-ago level) and handily smote even the high estimate on the Street. Revenue growth was definitely fueled by test and measurement business (up 27% sequentially), but the optical products business was no slouch at 14% sequential growth. While the Advanced Optical Technologies unit saw a 10% sequential revenue decline, analysts did not expect a lot from this business.
As revenue jumped ahead of plan, the company was able to leverage better profitability. Gross margin increased 140 basis points on a sequential basis, while the operating margin expanded 450 basis points to over 15%. (For more, see The Bottom Line On Margins.)
The Road Ahead
If management is right, this was not a one-quarter recovery in JDS Uniphase's business. The company guided for a level of March quarter revenue that looks to be about 7% higher than where estimates had been, and while there could be some sequential pullback in profitability, it would seem that numbers should be going up overall.
Please click below for the full piece:
http://stocks.investopedia.
A Blowout in the Fiscal Second Quarter
JDS Uniphase delivered everything investors wanted in its fiscal second quarter and then some. Revenue jumped 16% from the first quarter (and 39% from the year-ago level) and handily smote even the high estimate on the Street. Revenue growth was definitely fueled by test and measurement business (up 27% sequentially), but the optical products business was no slouch at 14% sequential growth. While the Advanced Optical Technologies unit saw a 10% sequential revenue decline, analysts did not expect a lot from this business.
As revenue jumped ahead of plan, the company was able to leverage better profitability. Gross margin increased 140 basis points on a sequential basis, while the operating margin expanded 450 basis points to over 15%. (For more, see The Bottom Line On Margins.)
The Road Ahead
If management is right, this was not a one-quarter recovery in JDS Uniphase's business. The company guided for a level of March quarter revenue that looks to be about 7% higher than where estimates had been, and while there could be some sequential pullback in profitability, it would seem that numbers should be going up overall.
Please click below for the full piece:
http://stocks.investopedia.
Subscribe to:
Posts (Atom)